Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research. The findings are presented at the European Association of Urology Congress (EAU26) in London. The research has also been accepted for publication in European Urology.
Continue Reading this article here
